Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
PCSK9 Inhibitors: Contraindications & Drug Interactions
Safety information for PCSK9 Inhibitors including known contraindications, drug interactions, and important precautions.
Back to PCSK9 Inhibitors overviewContraindications
- hypersensitivity to active substance or excipients
- severe active liver disease (caution)
- pregnancy (limited data — use only if benefit outweighs risk)
Drug Interactions (4 interactions)
Important: This table summarizes known and theoretical interactions. Always consult a healthcare provider before combining PCSK9 Inhibitors with any medication.
| Drug | Classification | Mechanism |
|---|---|---|
| bile acid sequestrants | Documented | Separate administration by at least 1 hour to avoid absorption interference |
| fibrates | Theoretical | Limited interaction data — monitor when co-administered |
| statins | No Known Interaction | No interaction — combination is the intended clinical use for enhanced LDL lowering |
| ezetimibe | No Known Interaction | No interaction — standard co-administration |
Use our interactive Drug Interaction Checker for real-time lookup.